Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 80Lymphoma, Non-Hodgkin 73Leukemia, Lymphocytic, Chronic, B-Cell 70Hodgkin Disease 64Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Multiple Myeloma 58Myeloproliferative Disorders 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 44Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 43Neoplasms, Plasma Cell 41Hematologic Neoplasms 35Graft vs Host Disease 35Primary Myelofibrosis 33Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32Dendritic Cell Sarcoma, Interdigitating 32

Interventions

entinostat 1Radiotherapy 1Methylprednisolone 1Melphalan 1Imatinib Mesylate 1Fentanyl 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Busulfan × Other hematologic neoplasm × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡